If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Baqsimi is contraindicated in patients with
known hypersensitivity to glucagon or to any of the excipients of Baqsimi.1
Enclosed Prescribing Information
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: July 24, 2019